Results of intracavitary radium treatment for adenocarcinoma of the body of the uterus
References (13)
- et al.
Carcinoma of the endometrium, results of treatment
International Journal of Radiation Oncology, Biology, Physics
(1980) Carcinoma corporis uteri: a radical intracavitary treatment
Clinical Radiology
(1965)- et al.
Evaluation of primary radiation therapy in Stage 1, Group 2, endometrial carcinoma
Radiology
(1969) Staging of endometrial cancer
International Journal of Radiation Oncology, Biology, Physics
(1980)- et al.
Female genital tract
Acta Obstetrica et Gynecologica Scandinavica
(1971)
Cited by (23)
High Dose Rate Brachytherapy for Inoperable Endometrial Cancer: a Case Series and Systematic Review of the Literature
2021, Clinical OncologyCitation Excerpt :Brachytherapy for the sole management of endometrial carcinoma was first described by Heyman in 1935, prior to the routine use of hysterectomy for uterine cancer [7]. Initially, low dose rate (LDR) brachytherapy with Ra-226 or Cs-137 was carried out [8–20]. Recent advances in gynaecological brachytherapy have shifted the brachytherapy treatment planning from LDR brachytherapy to high dose rate (HDR) brachytherapy [21,22].
Systemic review: Radiation therapy alone in medical non-operable endometrial carcinoma
2016, European Journal of CancerPilot study in the treatment of endometrial carcinoma with 3D image-based high-dose-rate brachytherapy using modified Heyman packing: Clinical experience and dose-volume histogram analysis
2005, International Journal of Radiation Oncology Biology PhysicsImage-based intracavitary brachytherapy in the treatment of inoperable uterine cancer: Individual dose specification at specific anatomical sites
2005, BrachytherapyCitation Excerpt :Fortunately, 75% of women have Stage I disease at the time of diagnosis. Although a total abdominal hysterectomy with bilateral salpingo-oophorectomy is the standard treatment for organ-confined endometrial cancer, patients with high operative risk due to underlying medical conditions have been treated using intracavitary brachytherapy (ICBT) with or without pelvic external beam treatment (2–4). Although the dose specification of ICBT for cervical cancer was well established as Point A in the early days of radium therapy, there is still no consensus on which standard reference point should be used for endometrial cancer.
Analgesia for pelvic brachytherapy
2002, British Journal of AnaesthesiaCitation Excerpt :The treatment of choice for most patients with endometrial cancer is simple hysterectomy, with cure rates of 80–90% if the tumour is confined to the uterus.1 In patients considered unfit for surgery, intracavity brachytherapy can result in a 5-yr survival of up to 73%.14 Manually inserted radiation sources provide ‘gold standard’ treatment results at the expense of radiation exposure of staff.
Standards, options and recommendations for radiotherapy of carcinoma of the endometrium
2001, Cancer/Radiotherapie